Kåre Schultz

President and Chief Executive Officer (“ CEO ”)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

TEVA

CEO, Board Member

2017-01-01–2022-12-31

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2022	Teva Pharmaceutical Industries Ltd (TEVA)	President and Chief Executive Officer	$2,000,000	$0	$9,999,990	$0	$2,824,360	$704,788	$15,529,138
2021	Teva Pharmaceutical Industries Ltd (TEVA)	President and Chief Executive Officer	$2,000,000	$0	$9,999,994	$0	$2,029,440	$652,338	$14,681,772
2020	Teva Pharmaceutical Industries Ltd (TEVA)	President and Chief Executive Officer	$2,000,000	$0	$9,999,970	$0	$3,055,920	$668,628	$15,724,518
2019	Teva Pharmaceutical Industries Ltd (TEVA)	President and Chief Executive Officer	$2,000,000	$0	$5,999,977	$0	$2,869,720	$726,867	$11,596,564
2018	Teva Pharmaceutical Industries Ltd (TEVA)	President and Chief Executive Officer	$2,000,000	$20,000,000	$4,499,977	$1,500,019	$3,790,360	$679,519	$32,469,875
2017	Teva Pharmaceutical Industries Ltd (TEVA)	President and Chief Executive Officer	$333,333	$0	$14,229,808	$2,000,009	$0	$464,591	$17,027,741

No earnings-call appearances or filed executive changes recorded yet.